A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma

Clinical trial NCT06843434 · RECRUITING

Trial details

NCT number: NCT06843434
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Microsatellite Stable Rectal Carcinoma Locally Advanced Rectal Adenocarcinoma

Start date: 2025-02-20
Primary completion: 2028-02-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.